Greg Bohlmann has extensive and diverse experience in business analysis within the industrial biotech and chemical industries, with recent experience on biochemical business development. His most recent position was Director Biochemical Business Development for DuPont Industrial Biosciences. In this role, his primary project was the BioIsoprene collaboration with Goodyear Tire & Rubber where he developed key elements of commercialization including feedstock considerations, pilot plant site selection, and government funding opportunities. He also provided competitive intelligence and scouted for new biochemical development opportunities.Before his business development activity with Genencor and DuPont, Mr. Bohlmann was a key leader of SRI Consulting's Process Economics Program (PEP). He was responsible for building the industrial biotech core competency within PEP and developed over 60 technoeconomic models during the course of authoring 20 PEP studies.